Muscle Multi-parametric NMR Imaging Development in Aged People With Sarcopenia or Frailty Syndrome; CLINical Study (MIDAS)
Frail Elderly Syndrome, Diabetes
About this trial
This is an interventional other trial for Frail Elderly Syndrome focused on measuring imaging, myosteatosis (Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and fibrosis following skeletal muscle injury)
Eligibility Criteria
Inclusion Criteria:
- Robust or frail or pre-frail with at least 25% frail and 25% pre-frail according to Frieds criteria
- Barthel index > or = 60/100
- With or without diabetes mellitus, 45 to 55 % with known diabetes mellitus
- With no contraindication to undergo an MRI examination
Exclusion Criteria:
- not willing to participate
- not able to give informed consent or to understand basic instruction due to any problem (sensorial, educational, language)
- without social insurance
- with a legal protection
- with significant cognitive alteration (MMSe<21/30 or in case of low literacy <19/30)
- with a recent (2 month period) severe event: hospitalization, sepsis, stroke even with complete recovery, trauma
- with stroke sequelae (motor, speech)
Sites / Locations
- Service de Médecine Gériatrique, CHU de LIMOGES
- Service de gériatrie - CHU Bordeaux - hôpital Xavier ArnozanRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Frail/prefrail
non frail
Fried's criteria >3 = frail, 1 or 2 = prefrail The 5 Fried criteria mainly target the muscle function: low muscle strength, decreased physical activity and low gait speed. One refers to depressive symptoms with the use of 2 CES-D (Centre for Epidemiologic Studies - Depression Scale) questions and one to nutrition with the weight loss criteria. The second most famous definition of frailty was developed by ROCKWOOD and MITNISIKI (2). It describes frailty as the accumulation of deficits including cognitive, functional and social alterations
No Fried's criteria